Your browser doesn't support javascript.
loading
Angiomotin-p130 inhibits vasculogenic mimicry formation of small cell lung cancer independently of Smad2/3 signal pathway.
Li, Dan; Shen, Yanwei; Ren, Hui; Wang, Li; Yang, Jin; Wang, Yuan.
Affiliation
  • Li D; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
  • Shen Y; Department of Medical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
  • Ren H; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
  • Wang L; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
  • Yang J; Department of Medical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China. yangjin@mail.xjtu.edu.cn.
  • Wang Y; Department of Medical Imaging, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, People's Republic of China. Yuanw_123@163.com.
J Bioenerg Biomembr ; 53(3): 295-305, 2021 06.
Article in En | MEDLINE | ID: mdl-33712992
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Smad2 Protein / Small Cell Lung Carcinoma / Angiomotins / Lung Neoplasms Limits: Animals / Humans Language: En Journal: J Bioenerg Biomembr Year: 2021 Type: Article Affiliation country: China
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Smad2 Protein / Small Cell Lung Carcinoma / Angiomotins / Lung Neoplasms Limits: Animals / Humans Language: En Journal: J Bioenerg Biomembr Year: 2021 Type: Article Affiliation country: China